Bristol-Myers Squibb pays $14 million to resolve China FCPA offenses

By Richard L. Cassin, Published on The FCPA Blog on October 5th, 2015 The Securities and Exchange Commission said Monday that Bristol-Myers Squibb agreed to settle charges that its joint venture in China made cash payments and provided other benefits to health care providers at state-owned and state-controlled hospitals in exchange for prescription sales. –…

China amends its Criminal Law: Impact on anti-bribery enforcement

By Eric Carlson and Ping An, Published on The FCPA Blog on September 1st, 2015. On August 29, China’s National People’s Congress (NPC) adopted a slate of amendments to the country’s Criminal Law . . .  [ Read More ] Related Event: The American Conference Institute’s fourth annual Asia-Pacific Summit on Anti-Corruption, Compliance and Risk Management will address innovations…

ACI’s 2nd Annual Singapore Summit on Anti-Corruption, Compliance and Risk Management

A groundbreaking international conference like no other in the region. When: Tuesday, December 03 to Wednesday, December 04, 2013  Where: Singapore Marriott, Singapore To learn more & register: Click Here Industry Related News    Is corporate Singapore being too naive on fraud? Posted on CNBC.com by Katie Holliday Singaporean corporations are more naive in their approach to…